NIM
RVMD icon

NEOS Investment Management’s Revolution Medicines RVMD Stock Holding History

NEOS Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-101,888
Closed -$8.12M – 643
2025
Q4 		$8.12M Sell
101,888
-25,033
-20% -$1.64M 0.05% 259
2025
Q3 		$5.93M Buy
126,921
+32,694
+35% +$1.28M 0.04% 281
2025
Q2 		$3.47M Sell
94,227
-351
-0.4% -$13.5K 0.04% 291
2025
Q1 		$3.34M Buy
94,578
+46,339
+96% +$1.88M 0.06% 249
2024
Q4 		$2.11M Buy
48,239
+10,157
+27% +$513K 0.05% 290
2024
Q3 		$1.73M Buy
38,082
+5,779
+18% +$252K 0.05% 288
2024
Q2 		$1.25M Buy
32,303
+16,919
+110% +$632K 0.05% 296
2024
Q1 		$496K Buy
15,384
+4,480
+41% +$133K 0.03% 384
2023
Q4 		$313K Buy
+10,904
New +$262K 0.03% 375

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEOS Investment Management's RVMD Position: Q1 2026 in Review

NEOS Investment Management sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 101,888 shares — an estimated $8.12M sold.

NEOS Investment Management first reported a position in RVMD in Q4 2023 and held it in 9 quarters. The position peaked at $8.12M in Q4 2025. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • NEOS Investment Management reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 101,888 Revolution Medicines shares in Q1 2026, an estimated $8.12M.
  • NEOS Investment Management first reported a position in Revolution Medicines in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Revolution Medicines position peaked at $8.12M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.